
CPHI South East Asia 2026
07/2026 – 07/2026
KI Pharma Group successfully supports EU/PIC's/WHO GMP certifications for companies in Asia, and with its headquarters based in the EU and group partners in Brazil and Australia, provides high-value market access to the EU, Australia and Latin America. Its strengths span market access, product sourcing, R&D, dossier and regulatory support, and high-level GMP expertise covering all key activities in QA, QC, production and engineering, registered under company number FN 371197 d.



댓글이 없습니다.
평가 & 댓글 남기기